As of 2026-03-29, the Relative Valuation of Viracta Therapeutics Inc (VIRX) is (176.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Viracta Therapeutics Inc based on Relative Valuation is -227089.8%.
The range of the Relative Valuation is (173.75) - (182.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.1x - 23.0x | 20.9x |
| Forward P/E multiples | 19.2x - 21.1x | 20.0x |
| Fair Price | (173.75) - (182.56) | (176.60) |
| Upside | -223426.8% - -234748.6% | -227089.8% |
| Date | P/E |